Glasgow-Blatchford Score for Upper GI Bleeding

Clinical Overview & History

The Glasgow-Blatchford Score (GBS), published by Dr. Oliver Blatchford and colleagues in The Lancet in 2000, is a widely validated clinical prediction rule designed to risk-stratify patients presenting with acute upper gastrointestinal bleeding (UGIB) in the emergency department. Unlike older risk scores (such as the Rockall Score), the GBS relies entirely on non-invasive clinical findings and baseline laboratory parameters.

Because it does not require urgent diagnostic endoscopy to calculate, the GBS is highly useful at triage. Its primary clinical utility lies in its exceptional negative predictive value: identifying low-risk patients who can be safely managed as outpatients, thereby reducing unnecessary hospital admissions, conserving intensive care resources, and avoiding invasive procedures.

Pathophysiology and Clinical Markers

Upper GI bleeding typically arises from peptic ulcer disease, esophageal varices, Mallory-Weiss tears, or severe gastroduodenitis. Severe hemorrhage leads to systemic hypoperfusion, orthostatic hypotension, and compensatory tachycardia.

The GBS combines laboratory values, vital signs, and clinical presentation details to calculate a score from 0 to 23:

1. Blood Urea Nitrogen (BUN): Elevated urea is a hallmark of upper GI bleeding. When blood enters the upper GI tract, its proteins are digested and absorbed as they pass through the small intestine, leading to a marked rise in BUN.
2. Hemoglobin (Hb): Reflects the red blood cell mass. A low hemoglobin indicates severe or chronic blood loss.
3. Systolic Blood Pressure (SBP): Hypotension reflects intravascular volume depletion and hemorrhagic shock.
4. Heart Rate: Tachycardia ($ge 100\text{ bpm}$) is a compensatory mechanism for hypovolemia.
5. Presentation with Melena (1 point): Indicates digested blood in the stool, typical of upper GI source.
6. Presentation with Syncope (2 points): Indicates acute cerebral hypoperfusion due to rapid blood loss.
7. Hepatic Disease (2 points): Known history of cirrhosis or portal hypertension, which increases the likelihood of esophageal variceal bleeding.
8. Cardiac Failure (2 points): Chronic heart failure limits the patient's physiological ability to compensate for acute blood loss.

Formula & Scoring Interpretation

The total score is calculated as follows:

The points are derived from specific ranges (e.g., BUN $ge 70.0\text{ mg/dL}$ adds 6 points; SBP $< 90\text{ mmHg}$ adds 3 points; Hb $< 10.0\text{ g/dL}$ adds 6 points).

• Score = 0: Extremely low risk. The risk of requiring clinical intervention (blood transfusion, therapeutic endoscopy, interventional radiology, or surgery) or 30-day mortality is $< 1%$. These patients are suitable for safe discharge with outpatient follow-up.
• Score = 1: Low risk, but clinical discretion is required. Some guidelines permit outpatient management if the patient is young, has good social support, and has no high-risk comorbidities.
• Score ge 2: Elevated risk. These patients typically require inpatient admission, monitoring, and diagnostic endoscopy to identify and manage the source of bleeding.

Step-by-Step Clinical Scenario

Consider a clinical case: A 54-year-old female presents to the emergency department complaining of vomiting dark, coffee-ground-like material and feeling lightheaded. She has a history of osteoarthritis and takes ibuprofen daily. On examination:

• Systolic BP: $105\text{ mmHg}$ (1 point)
• Heart Rate: $102\text{ bpm}$ (1 point)
• Presentation: She reports black, tarry stools (melena) (1 point), but no syncope (0 points).
• History: No history of cardiac failure or liver disease (0 points).
• Laboratory results: Hemoglobin is $11.2\text{ g/dL}$ (3 points), and BUN is $24.0\text{ mg/dL}$ (3 points).

Let's calculate the GBS Score:

$\text{GBS Score} = 3 (\text{BUN}) + 3 (\text{Hb}) + 1 (\text{SBP}) + 1 (\text{HR}) + 1 (\text{Melena}) + 0 (\text{Syncope}) + 0 (\text{Hepatic}) + 0 (\text{Cardiac}) = 9\text{ points}$

A score of 9 indicates a high risk of requiring clinical intervention. The patient should be admitted, started on intravenous proton pump inhibitors (PPIs), typed and screened for potential blood transfusion, and scheduled for an early diagnostic upper endoscopy (EGD).

Clinical Utility and Limitations

GBS is highly sensitive ($>99%$) for predicting the need for intervention, making it an excellent triage tool. However, it is not specific; many patients with moderate scores will not end up needing active intervention but still require hospital admission for observation. Additionally, it does not locate the source of bleeding, which requires endoscopic visualization.

⚠️ Medical Disclaimer: This calculator is for educational and reference purposes only. It is not intended to diagnose, treat, or cure any disease, and should not be used as a substitute for professional clinical judgment.